7210 Wareham Drive, Tampa, FL 33647
Nov. 6, 2025 Weight loss products are a major part of Herbalife’s business, accounting for 55% of total sales for the first nine months of 2025. According to Stephan Gratziani, CEO,… “Herbalife’s third-quarter performance reflects continued progress in our transformation strategy, as well as disciplined financial and operational execution. With North America returning to growth […]
Herbalife Reports 3rd Qtr. Results Read More »
Oct. 31, 2025 Zach Yadegari is the 18-year old co-founder and CEO of Cal AI, a calorie-tracking mobile app he launched from his parents’ home in Roslyn, New York, in May 2024. It has amassed 8.3 million downloads so far and growing. The company says that it nets $1.4 million per month profit, after expenses,
Sucess Story – Cal AI Weight Loss App Read More »
March 24, 2025 Marketdata LLC has just published a new report: “The U.S. Weight Loss Market: Commercial (non-medical) Programs & Products”, March 2025. This is a 220-page analysis of commercial weight loss programs/companies and how they have been affected by and respond to the onslaught of the GLP-1 drugs competition. The $38 billion U.S. commercial weight loss
$38.4 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion Read More »
Sept. 25, 2024 Lindora Clinics, a regional medical weight loss chain based in California, has recently begun franchising. As such, it has filed a 2024 FDD (Franchise Disclosure Document) that describes the franchise, its investment costs, etc. Lindora is a long-established company in the weight loss market, with a variety of weight loss programs, both
Lindora Clinics Franchise Is Well Diversified Read More »
Sept. 12, 2024 Noom is the latest weight loss company to start prescribing compounded versions of the obesity medication semaglutide. This follows similar moves by Hims, Ro, and other telehealth companies capitalizing on shortages of brand-name obesity drugs. Noom will sell the compounded GLP-1 drug starting at $149 a month, it says. The company, which
Noom Offers Compounded Weight Loss Drugs Read More »
April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for weight loss programs delivered via telehealth / telemedicine companies is worth $6.9 billion, and growing. Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their
Telehealth Weight Loss Market Worth $6.9 Billion And Growing Read More »
Feb. 24, 2022 It’s official now. Medifast, an MLM model company, has surpassed Weight Watchers as the world’s largest weight loss provider, with 2021 revenues of $1.5 billion. CEO Dan Chard said that: “With this engine powering our momentum, we have moved from $275 million in revenue prior to the launch of OPTAVIA and the
Medifast Reports Q4, Full Year Results, Becomes Largest Weight Loss Company by Sales Read More »
Feb. 3, 2022 As reported here and in many other publications, Noom’s rapid growth as a weight loss program is well known. The company may plan an IPO this year, and it’s estimated that revenues topped $600 million last year. The company has raised $669 million to date. However, there may be some weak spots.
Dec. 13, 2021 As reported in a recent INC. magazine article, a survey by the American Psychological Association found that some 42 percent of U.S. adults gained unwanted weight in the first year of the pandemic. This helps explain the boom year Noom had for its weight-loss service in 2020, with sales estimated at more
Americans Add Weight During Pandemic, Noom Prospers Read More »
May 19, 2021 Noom Inc., a popular app targeted to help weight loss, is said to have obtained funding from the private equity firm Silver Lake ahead of a potential IPO. Noom is said to be worth $4 billion in its latest funding round, according to a Bloomberg report yesterday. The company, which hopes to be
Noom, Weight Loss App Company, Eyes Possible IPO Read More »